The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oral Thin Film Drugs-Global Market Insights and Sales Trends 2024
Synopsis
The global Oral Thin Film Drugs market size is expected to reach US$ 2677.2 million by 2029, growing at a CAGR of 10.9% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Thin Film Drugs in various end use industries. The expanding demands from the Schizophrenia, Migraine, Opioid Dependence and Nausea & Vomiting, are propelling Oral Thin Film Drugs market. Sublingual Film, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fully Dissolving Dental/Buccal Film segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Oral Thin Film Drugs market, driven by demand from China, the second largest economy with some signs of stabilising, the Oral Thin Film Drugs market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Thin Film Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Thin Film Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Thin Film Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Thin Film Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Thin Film Drugs covered in this report include Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG, ZIM Laboratories Limited, Indivior Plc., Allergan Plc., IntelGenx Corp, NAL Pharma and Wolters Kluwer, etc.
The global Oral Thin Film Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sumitomo Dainippon Pharma Co., Ltd.
Pfizer
Novartis AG
ZIM Laboratories Limited
Indivior Plc.
Allergan Plc.
IntelGenx Corp
NAL Pharma
Wolters Kluwer
Global Oral Thin Film Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Thin Film Drugs market, Segment by Type:
Sublingual Film
Fully Dissolving Dental/Buccal Film
Global Oral Thin Film Drugs market, by Application
Schizophrenia
Migraine
Opioid Dependence
Nausea & Vomiting
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Thin Film Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Thin Film Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Oral Thin Film Drugs market size is expected to reach US$ 2677.2 million by 2029, growing at a CAGR of 10.9% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Thin Film Drugs in various end use industries. The expanding demands from the Schizophrenia, Migraine, Opioid Dependence and Nausea & Vomiting, are propelling Oral Thin Film Drugs market. Sublingual Film, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fully Dissolving Dental/Buccal Film segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Oral Thin Film Drugs market, driven by demand from China, the second largest economy with some signs of stabilising, the Oral Thin Film Drugs market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Thin Film Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Thin Film Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Thin Film Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Thin Film Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Thin Film Drugs covered in this report include Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG, ZIM Laboratories Limited, Indivior Plc., Allergan Plc., IntelGenx Corp, NAL Pharma and Wolters Kluwer, etc.
The global Oral Thin Film Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sumitomo Dainippon Pharma Co., Ltd.
Pfizer
Novartis AG
ZIM Laboratories Limited
Indivior Plc.
Allergan Plc.
IntelGenx Corp
NAL Pharma
Wolters Kluwer
Global Oral Thin Film Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Thin Film Drugs market, Segment by Type:
Sublingual Film
Fully Dissolving Dental/Buccal Film
Global Oral Thin Film Drugs market, by Application
Schizophrenia
Migraine
Opioid Dependence
Nausea & Vomiting
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Thin Film Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Thin Film Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Oral Thin Film Drugs Market Overview
1.1 Oral Thin Film Drugs Product Overview
1.2 Oral Thin Film Drugs Market Segment by Type
1.2.1 Sublingual Film
1.2.2 Fully Dissolving Dental/Buccal Film
1.3 Global Oral Thin Film Drugs Market Size by Type
1.3.1 Global Oral Thin Film Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Oral Thin Film Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oral Thin Film Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Thin Film Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oral Thin Film Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oral Thin Film Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oral Thin Film Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oral Thin Film Drugs Sales Breakdown by Type (2018-2023)
2 Global Oral Thin Film Drugs Market Competition by Company
2.1 Global Top Players by Oral Thin Film Drugs Sales (2018-2023)
2.2 Global Top Players by Oral Thin Film Drugs Revenue (2018-2023)
2.3 Global Top Players by Oral Thin Film Drugs Price (2018-2023)
2.4 Global Top Manufacturers Oral Thin Film Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Thin Film Drugs Market Competitive Situation and Trends
2.5.1 Oral Thin Film Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Thin Film Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Thin Film Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Thin Film Drugs Market
2.8 Key Manufacturers Oral Thin Film Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Thin Film Drugs Status and Outlook by Region
3.1 Global Oral Thin Film Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oral Thin Film Drugs Historic Market Size by Region
3.2.1 Global Oral Thin Film Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Oral Thin Film Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Oral Thin Film Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oral Thin Film Drugs Forecasted Market Size by Region
3.3.1 Global Oral Thin Film Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Oral Thin Film Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Oral Thin Film Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oral Thin Film Drugs by Application
4.1 Oral Thin Film Drugs Market Segment by Application
4.1.1 Schizophrenia
4.1.2 Migraine
4.1.3 Opioid Dependence
4.1.4 Nausea & Vomiting
4.1.5 Others
4.2 Global Oral Thin Film Drugs Market Size by Application
4.2.1 Global Oral Thin Film Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Oral Thin Film Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oral Thin Film Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Thin Film Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oral Thin Film Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oral Thin Film Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oral Thin Film Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oral Thin Film Drugs Sales Breakdown by Application (2018-2023)
5 North America Oral Thin Film Drugs by Country
5.1 North America Oral Thin Film Drugs Historic Market Size by Country
5.1.1 North America Oral Thin Film Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oral Thin Film Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Oral Thin Film Drugs Sales in Value by Country (2018-2023)
5.2 North America Oral Thin Film Drugs Forecasted Market Size by Country
5.2.1 North America Oral Thin Film Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Oral Thin Film Drugs Sales in Value by Country (2024-2029)
6 Europe Oral Thin Film Drugs by Country
6.1 Europe Oral Thin Film Drugs Historic Market Size by Country
6.1.1 Europe Oral Thin Film Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oral Thin Film Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Oral Thin Film Drugs Sales in Value by Country (2018-2023)
6.2 Europe Oral Thin Film Drugs Forecasted Market Size by Country
6.2.1 Europe Oral Thin Film Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Oral Thin Film Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Oral Thin Film Drugs by Region
7.1 Asia-Pacific Oral Thin Film Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Oral Thin Film Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oral Thin Film Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oral Thin Film Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oral Thin Film Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Thin Film Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oral Thin Film Drugs Sales in Value by Region (2024-2029)
8 Latin America Oral Thin Film Drugs by Country
8.1 Latin America Oral Thin Film Drugs Historic Market Size by Country
8.1.1 Latin America Oral Thin Film Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oral Thin Film Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oral Thin Film Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Oral Thin Film Drugs Forecasted Market Size by Country
8.2.1 Latin America Oral Thin Film Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oral Thin Film Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Oral Thin Film Drugs by Country
9.1 Middle East and Africa Oral Thin Film Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Oral Thin Film Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oral Thin Film Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oral Thin Film Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oral Thin Film Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Thin Film Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oral Thin Film Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sumitomo Dainippon Pharma Co., Ltd.
10.1.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
10.1.2 Sumitomo Dainippon Pharma Co., Ltd. Introduction and Business Overview
10.1.3 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Products Offered
10.1.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Oral Thin Film Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Oral Thin Film Drugs Products Offered
10.2.5 Pfizer Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Information
10.3.2 Novartis AG Introduction and Business Overview
10.3.3 Novartis AG Oral Thin Film Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis AG Oral Thin Film Drugs Products Offered
10.3.5 Novartis AG Recent Development
10.4 ZIM Laboratories Limited
10.4.1 ZIM Laboratories Limited Company Information
10.4.2 ZIM Laboratories Limited Introduction and Business Overview
10.4.3 ZIM Laboratories Limited Oral Thin Film Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 ZIM Laboratories Limited Oral Thin Film Drugs Products Offered
10.4.5 ZIM Laboratories Limited Recent Development
10.5 Indivior Plc.
10.5.1 Indivior Plc. Company Information
10.5.2 Indivior Plc. Introduction and Business Overview
10.5.3 Indivior Plc. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Indivior Plc. Oral Thin Film Drugs Products Offered
10.5.5 Indivior Plc. Recent Development
10.6 Allergan Plc.
10.6.1 Allergan Plc. Company Information
10.6.2 Allergan Plc. Introduction and Business Overview
10.6.3 Allergan Plc. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Allergan Plc. Oral Thin Film Drugs Products Offered
10.6.5 Allergan Plc. Recent Development
10.7 IntelGenx Corp
10.7.1 IntelGenx Corp Company Information
10.7.2 IntelGenx Corp Introduction and Business Overview
10.7.3 IntelGenx Corp Oral Thin Film Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 IntelGenx Corp Oral Thin Film Drugs Products Offered
10.7.5 IntelGenx Corp Recent Development
10.8 NAL Pharma
10.8.1 NAL Pharma Company Information
10.8.2 NAL Pharma Introduction and Business Overview
10.8.3 NAL Pharma Oral Thin Film Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 NAL Pharma Oral Thin Film Drugs Products Offered
10.8.5 NAL Pharma Recent Development
10.9 Wolters Kluwer
10.9.1 Wolters Kluwer Company Information
10.9.2 Wolters Kluwer Introduction and Business Overview
10.9.3 Wolters Kluwer Oral Thin Film Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Wolters Kluwer Oral Thin Film Drugs Products Offered
10.9.5 Wolters Kluwer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Thin Film Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Thin Film Drugs Industrial Chain Analysis
11.4 Oral Thin Film Drugs Market Dynamics
11.4.1 Oral Thin Film Drugs Industry Trends
11.4.2 Oral Thin Film Drugs Market Drivers
11.4.3 Oral Thin Film Drugs Market Challenges
11.4.4 Oral Thin Film Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Thin Film Drugs Distributors
12.3 Oral Thin Film Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
